| |
With all of these
new products and more to come, we hired and trained 17 new sales people
for our U.S. domestic sales force during 2005. We are optimistic that
they will contribute to future sales growth and improve market penetration. |
|
Our strategy is
to continue to invest in products for interventional radiology, which
is a fragmented area with many opportunities. We will also maintain
our focus on cardiology products, including new catheters that will
enhance our competitive advantage. We will consider acquisitions of
products or technologies that help to enhance our core competencies
and market opportunities.
|
|
| |
|
|
|
Financial Results
For the year ended December 31, 2005,
the Company reported record revenue of $166.6 million, a 10% increase
over $151.4 million in revenue reported for the year ended December
31, 2004. In addition, the Company reported net income of $15.8
million, or $0.57 per share, for calendar year 2005. This
|
|
